ClinicalTrials.Veeva

Menu

4D Velocity Mapping of the Heart in rTOF Patients (CARDIOFLUX)

C

Centre Hospitalier Universitaire, Amiens

Status

Unknown

Conditions

Tetralogy of Fallot
Magnetic Resonance Imaging

Treatments

Device: 4D flow imaging

Study type

Interventional

Funder types

Other

Identifiers

NCT02980614
PI2016_843_0026

Details and patient eligibility

About

MRI with 4D flow permits to assess the hemodynamic parameters in a parent vessel and its branches inside the same sequence.

Full description

MRI with 4D flow permits to assess the hemodynamic parameters in a parent vessel and its branches inside the same sequence. The objective of the project is to compare the regurgitant fraction in the pulmonary artery (PA) measured using 4D MR-flow and standard 2D MR-flow in repaired Tetralogy of Fallot (rTOF) patients. The consistency of the 4D flow quantization will be assessed assuming mass conservation in the pulmonary artery tree (PA flow =LeftPA flow +RightPA flow ? ).

Enrollment

30 estimated patients

Sex

All

Ages

15+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Tetralogy of Fallot patients
  • referred for clinical MRI examination
  • ≥ 15 years

Exclusion criteria

  • Anyone with a classic contraindication to MRI
  • Severe obesity
  • Gadolinium chelate allergy
  • < 15 years
  • counter-indication to MRI examination
  • vulnerable person

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Participants to 4D flow imaging
Experimental group
Description:
In addition to the standard clinical MR protocol, 2 added sequences: 4D MR sequence in cine mode 4D velocity mapping sequence
Treatment:
Device: 4D flow imaging

Trial contacts and locations

1

Loading...

Central trial contact

Cedric Renard, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems